Showing results (81-90 of 294) with videos related to
Sort By:
Pageof 30
Frontiers in Oncology|May 25, 2017
Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and NeckAthanassios Argiris, Kevin J Harrington, Makoto Tahara, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 5, 2017
Eliciting Preferences for Clinical Follow-Up in Patients with Head and Neck Cancer Using Best-Worst ScalingMichela Meregaglia, John Cairns, Salvatore Alfieri, et al.Oral Oncology|July 9, 2014
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancerPaolo Bossi, Laura Locati, Cristiana Bergamini, et al.Heliyon|February 5, 2024
Developing a robust two-step machine learning multiclassification pipeline to predict primary site in head and neck carcinoma from lymph nodesJiaying Liu, Anna Corti, Giuseppina Calareso, et al.Tumori|March 17, 2016
Safety of combination treatment with imatinib mesylate, carboplatin, and cetuximab in a patient with multiple cancers: a case reportLaura Pala, Cristiana Bergamini, Martina Imbimbo, et al.Critical Reviews in Oncology/Hematology|February 27, 2003
Cancer of the nasopharynxLisa Licitra, Jacques Bernier, Esteban Cvitkovic, et al.Frontiers in Oncology|February 11, 2020
Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Unsuitable to Receive Cisplatin-Based TherapySandro V Porceddu, Florian Scotté, Matti Aapro, et al.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 17, 2018
Use of apparent diffusion coefficient images to predict response to induction chemotherapy in sinonasal cancerMarco Bologna, Eros Montin, Valentina D A Corino, et al.Cancer Chemotherapy and Pharmacology|April 10, 2014
An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neckVassiliki Saloura, Ezra E W Cohen, Lisa Licitra, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinomaFederica Perrone, Paolo Bossi, Barbara Cortelazzi, et al.Pageof 30